California Public Employees Retirement System’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-40,600
Closed -$233K 1678
2021
Q1
$233K Sell
40,600
-3,817
-9% -$28.3K ﹤0.01% 3319
2020
Q4
$397K Buy
44,417
+2,917
+7% +$31.1K ﹤0.01% 3038
2020
Q3
$483K Buy
41,500
+1,300
+3% +$18.9K ﹤0.01% 2790
2020
Q2
$644K Buy
40,200
+29,867
+289% +$331K ﹤0.01% 2528
2020
Q1
$62K Buy
+10,333
New +$95.5K ﹤0.01% 3228

Other funds holding AUTL

California Public Employees Retirement System's AUTL Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Autolus Therapeutics (AUTL) in Q2 2021, closing a stake of 40,600 shares — an estimated $233K sold.

California Public Employees Retirement System first reported a position in AUTL in Q1 2020 and held it in 5 quarters. The position peaked at $644K in Q2 2020. 69 funds tracked by Wall St. Rank hold AUTL as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Autolus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 40,600 Autolus Therapeutics shares in Q2 2021, an estimated $233K.
  • California Public Employees Retirement System first reported a position in Autolus Therapeutics in Q1 2020 and held it in 5 quarters.
  • California Public Employees Retirement System's Autolus Therapeutics position peaked at $644K in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.